Cannabis company Columbia Care to cut costs and sell its Florida business
By Steve Gelsi
Cannabist, the parent of Columbia Care, to shed workers as part of $10 million in savings
Cannabist Co. Holdings Inc.'s stock rose Monday after it said it will reduce its workforce by an amount that has yet to be determined and divest its holdings in Florida as part of a plan to save $10 million a year.
The Cannabist (CBSTF), the parent of dispensary operator Columbia Care, said it will also divest assets "in other underperforming markets" in the coming months.
The stock rose 4% on Monday.
Columbia Care will focus on profitable markets such as Virginia and New Jersey. It's also planning to take part in the launch of recreational marijuana markets in Ohio and Delaware.
The move comes amid competition in Florida with larger players such as Trulieve Cannabis Corp. (TCNNF), Curaleaf Holdings Inc. (CURLF) and Green Thumb Industries (GTBIF).
Florida is holding a referendum vote on adult-use pot on the November ballot.
In January, Cannabist promoted its operating chief David Hart to chief executive.
The company had agreed to be acquired by Cresco Labs Inc. (CRLBF) in 2022 but the deal was called off in June of last year.
Cannabist's stock has fallen by 60% so far in 2024, compared to a 0.3% drop by the AdvisorShares Pure U.S. Cannabis ETF MSOS.
The stock has been trading under $1 a share since late 2023.
Verano sets first-ever stock buyback
Verano Holdings Corp.'s stock (VRNOF) rose by nearly 8% on Monday after the cannabis company said it plans to buy back $50 million of its own shares.
The transaction marks Verano's first stock purchase program since it went public three years ago.
"The authorization of our first-ever share repurchase program provides an additional outlet for capital deployment alongside other measures such as capital expenditures, strengthening our balance sheet, and potential M&A as we position Verano for long-term growth," said Chief Executive George Archos.
Verano's stock has fallen by 24.1% so far in 2024.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-17-24 1351ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
13 Charts On the Market’s Q2 Turnaround
-
10 Top-Performing Dividend Stocks of Q2 2024
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations
-
Real Estate: Interest Rate Movements Drive Performance
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities